Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1991 Sep;35(9):1940–1942. doi: 10.1128/aac.35.9.1940

Comparison of cefprozil and cefaclor for treatment of acute urinary tract infections in women.

A Iravani 1
PMCID: PMC245300  PMID: 1952874

Abstract

A total of 108 college women with acute urinary tract infections were treated for 10 days with either 500 mg of cefprozil (BMY-28100-03-800) once a day (n = 72) or 250 mg of cefaclor three times a day (n = 36). Clinical and bacterial cure rates at 1 week posttherapy were 94 and 93%, respectively, for the cefprozil group and 94 and 94%, respectively, for the cefaclor group (P, not significant). Both cefprozil and cefaclor were safe and effective.

Full text

PDF
1940

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barbhaiya R. H., Gleason C. R., Shyu W. C., Wilber R. B., Martin R. R., Pittman K. A. Phase I study of single-dose BMY-28100, a new oral cephalosporin. Antimicrob Agents Chemother. 1990 Feb;34(2):202–205. doi: 10.1128/aac.34.2.202. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Barbhaiya R. H., Shukla U. A., Gleason C. R., Shyu W. C., Wilber R. B., Martin R. R., Pittman K. A. Phase I study of multiple-dose cefprozil and comparison with cefaclor. Antimicrob Agents Chemother. 1990 Jun;34(6):1198–1203. doi: 10.1128/aac.34.6.1198. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Barbhaiya R. H., Shukla U. A., Gleason C. R., Shyu W. C., Wilber R. B., Pittman K. A. Comparison of cefprozil and cefaclor pharmacokinetics and tissue penetration. Antimicrob Agents Chemother. 1990 Jun;34(6):1204–1209. doi: 10.1128/aac.34.6.1204. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bauer A. W., Kirby W. M., Sherris J. C., Turck M. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol. 1966 Apr;45(4):493–496. [PubMed] [Google Scholar]
  5. CUTLER S. J., EDERER F. Maximum utilization of the life table method in analyzing survival. J Chronic Dis. 1958 Dec;8(6):699–712. doi: 10.1016/0021-9681(58)90126-7. [DOI] [PubMed] [Google Scholar]
  6. Chin N. X., Neu H. C. Comparative antibacterial activity of a new oral cephalosporin, BMY-28100. Antimicrob Agents Chemother. 1987 Mar;31(3):480–483. doi: 10.1128/aac.31.3.480. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Eliopoulos G. M., Reiszner E., Wennersten C., Moellering R. C., Jr In vitro activity of BMY-28100, a new oral cephalosporin. Antimicrob Agents Chemother. 1987 Apr;31(4):653–656. doi: 10.1128/aac.31.4.653. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Gurwith M. J., Stein G. E., Gurwith D. Prospective comparison of amoxicillin-clavulanic acid and cefaclor in treatment of uncomplicated urinary tract infections. Antimicrob Agents Chemother. 1983 Nov;24(5):716–719. doi: 10.1128/aac.24.5.716. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hooker K. D., DiPiro J. T. Effect of antimicrobial therapy on bowel flora. Clin Pharm. 1988 Dec;7(12):878–888. [PubMed] [Google Scholar]
  10. Iravani A. Loracarbef versus cefaclor in the treatment of urinary tract infections in women. Antimicrob Agents Chemother. 1991 Apr;35(4):750–752. doi: 10.1128/aac.35.4.750. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Iravani A., Pryor N., Richard G. A. Treatment of acute uncomplicated urinary tract infections by cephalexin, with special reference to the antibody-coated bacteria. Int J Clin Pharmacol Ther Toxicol. 1982 Mar;20(3):97–100. [PubMed] [Google Scholar]
  12. Iravani A., Richard G. A. Amoxicillin-clavulanic acid versus cefaclor in the treatment of urinary tract infections and their effects on the urogenital and rectal flora. Antimicrob Agents Chemother. 1986 Jan;29(1):107–111. doi: 10.1128/aac.29.1.107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Iravani A., Richard G. A., Johnson D., Bryant A. A double-blind, multicenter, comparative study of the safety and efficacy of cefixime versus amoxicillin in the treatment of acute urinary tract infections in adult patients. Am J Med. 1988 Sep 16;85(3A):17–23. doi: 10.1016/0002-9343(88)90459-7. [DOI] [PubMed] [Google Scholar]
  14. Iravani A., Richard G. A. Single-dose ceftriaxone versus multiple-dose trimethoprim-sulfamethoxazole in the treatment of acute urinary tract infections. Antimicrob Agents Chemother. 1985 Feb;27(2):158–161. doi: 10.1128/aac.27.2.158. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Jordan P. A., Iravani A., Richard G. A., Baer H. Urinary tract infection caused by Staphylococcus saprophyticus. J Infect Dis. 1980 Oct;142(4):510–515. doi: 10.1093/infdis/142.4.510. [DOI] [PubMed] [Google Scholar]
  16. Leitner F., Pursiano T. A., Buck R. E., Tsai Y. H., Chisholm D. R., Misiek M., Desiderio J. V., Kessler R. E. BMY 28100, a new oral cephalosporin. Antimicrob Agents Chemother. 1987 Feb;31(2):238–243. doi: 10.1128/aac.31.2.238. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Nord C. E., Heimdahl A., Lundberg C., Marklund G. Impact of cefaclor on the normal human oropharyngeal and intestinal microflora. Scand J Infect Dis. 1987;19(6):681–685. doi: 10.3109/00365548709117204. [DOI] [PubMed] [Google Scholar]
  18. Nye K., O'Neill P., Andrews J. M., Wise R. Pharmacokinetics and tissue penetration of cefprozil. J Antimicrob Chemother. 1990 May;25(5):831–835. doi: 10.1093/jac/25.5.831. [DOI] [PubMed] [Google Scholar]
  19. Scribner R. K., Marks M. I., Finkhouse B. D. In vitro activity of BMY-28100 against common isolates from pediatric infections. Antimicrob Agents Chemother. 1987 Apr;31(4):630–631. doi: 10.1128/aac.31.4.630. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Sides G. D., Franson T. R., DeSante K. A., Black H. R. A comprehensive review of the clinical pharmacology and pharmacokinetics of cefaclor. Clin Ther. 1988;11 (Suppl A):5–19. [PubMed] [Google Scholar]
  21. Smith P. B., Tomfohrde K. M., Rhoden D. L., Balows A. API system: a multitube micromethod for identification of Enterobacteriaceae. Appl Microbiol. 1972 Sep;24(3):449–452. doi: 10.1128/am.24.3.449-452.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES